January 15, 2018

BARC and Biogazelle announce collaboration for advanced genetic testing in clinical trials

Bio Analytical Research Corporation (BARC), the global central laboratory division of Cerba HealthCare, today announces that Biogazelle will join the pool of expert laboratories they consistently collaborate with.
January 1, 2018

Meet Biogazelle at these events early 2018

III Symposium on Liquid Biopsies in Spain, the 2nd annual Precision LBx Summit in the United States and the 13th Annual Biomarkers Congress in the United Kingdom
October 10, 2017

Meet Biogazelle at these events in fall 2017

Genesis Drug Discovery, BIO-Europe 2017 and 4BIO Summit: 5th qPCR & Digital PCR Congress
September 18, 2017

Learn from the expert: digital PCR analysis of liquid biopsies

Thanks to recent technological developments, droplet digital PCR (ddPCR) has become an affordable technology for absolute quantification of nucleic acids in biological samples. Droplet digital PCR has several advantages over quantitative PCR as it does not require a calibration curve and is less susceptible to inhibition, providing a more accurate and precise quantification of template DNA molecules and providing a higher resolution to discriminate low frequent sequence variants (e.g. rare mutations in cancer or copy number variant detection).